Skip to search.
 TSX Up 1.59% TSX Ventures Down 0.37%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
1.87 Down 0.06(3.11%) Jul 29, 4:00PM EDT
Add to Portfolio
Prev Close:1.93
Open:1.90
Bid:1.87 x 5000
Ask:1.89 x 5000
1y Target Est:5.50
Beta:1.64
Next Earnings Date: 6-Aug-15CTIC Earnings announcement
Day's Range:1.85 - 1.90
52wk Range:1.65 - 2.94
Volume:681,341
Avg Vol (3m):3,220,000
Market Cap:337.04M
P/E (ttm):N/A
EPS (ttm):-0.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CTICDown 3.11%337.04M
BMYUp 0.36%108.20B
RHHBYUp 0.05%245.78B
SNYDown 2.17%137.65B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.38
Quarterly EPS Est (Jun-15) :-0.10
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback